Israeli lipids ingredients specialist Enzymotec has acquired an American supplement developer in a move to revitalize its stumbling medical foods subsidiary that has run into regulatory difficulties in the United States.
DSM has completed a major milestone in its restructuring into a smaller, more profitable and more focused company as it finalized the sale of its pharmaceutical manufacturing assets to US-based Thermo Fisher Scientific Inc.
Evolva will cut its workforce by 43% and spin off its Indian R&D laboratory to become a product-based company. "Technology will always be the backbone at Evolva but we've reached the point where we need to be laser focused on commercialising...
A prebiotic nanofibre matrix that protects beneficial bacteria in the low pH environment of fruit juices could prove an effective encapsulation agent for the probiotic delivery in functional beverages.
A formula supplement containing anti-oxidants plus zinc appears to be cost-effective in slowing the progression of the ‘wet’ form of the most common degenerative eye disease, finds a new study in British Journal of Ophthalmology.